Compared to the HAIT group, the HAIT-M-P group exhibited a higher incidence of fever, decreased appetite, neutropenia, elevated bilirubin, and hypoalbuminemia, which are primarily considered to be related to the cumulative toxicity of molecular targeted therapies and PD-(L)1 inhibitors (44–46). Here, CD274 is linked to neutropenia.